{"Symbol": "AIMD", "AssetType": "Common Stock", "Name": "Ainos Inc", "Description": "Ainos, Inc., a healthcare company, is dedicated to the development of medical technologies for safe and novel point-of-care testing and medical treatment for disease indications. The company is headquartered in San Diego, California.", "CIK": "1014763", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "TECHNOLOGY", "Industry": "SCIENTIFIC & TECHNICAL INSTRUMENTS", "Address": "8880 RIO SAN DIEGO DRIVE, SAN DIEGO, CA, UNITED STATES, 92108", "OfficialSite": "https://www.ainos.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-06-30", "MarketCapitalization": "12309700", "EBITDA": "-9806200", "PERatio": "None", "PEGRatio": "None", "BookValue": "2.681", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-4.52", "RevenuePerShareTTM": "0.036", "ProfitMargin": "0", "OperatingMarginTTM": "-803.28", "ReturnOnAssetsTTM": "-0.306", "ReturnOnEquityTTM": "-0.978", "RevenueTTM": "110870", "GrossProfitTTM": "91230", "DilutedEPSTTM": "-4.52", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "4.124", "AnalystTargetPrice": "None", "AnalystRatingStrongBuy": "-", "AnalystRatingBuy": "-", "AnalystRatingHold": "-", "AnalystRatingSell": "-", "AnalystRatingStrongSell": "-", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "93.9", "PriceToBookRatio": "1.057", "EVToRevenue": "181.23", "EVToEBITDA": "-1.6", "Beta": "2.37", "52WeekHigh": "4.5", "52WeekLow": "1.52", "50DayMovingAverage": "3.554", "200DayMovingAverage": "3.058", "SharesOutstanding": "4771200", "SharesFloat": "2356600", "PercentInsiders": "56.463", "PercentInstitutions": "0.640", "DividendDate": "None", "ExDividendDate": "None"}